doi:10.3390/cosmetics2030236 Pickart L, Vasquez-Soltero JM, Margolina A
Furthermore, the L-carnitine group exhibited greater reductions in anthropometric parameters, including lean body mass (LBM) and body fat mass (BFM), relative to the placebo group (Nachvak et al
Scharpf et al., 2007), with particularly elevated expression in the putamen and substantia nigra (Shetty and Copeland, 2018b)
Including specific clinical trial data showing the efficacy of the prescribed GLP-1 medication for patients with your BMI range and comorbidities strengthens the case considerably
Taken together, these results confirm the efficacy of liraglutide, particularly at the 3.0 mg dose, for improved fasting and postprandial glycemic control in obese individuals without T2DM
That distinction is where many dosage discussions get blurry